AMD and Cohere Expand Global AI Collaboration to Power Enterprise and Sovereign Deployments with AMD AI Infrastructure

— Cohere customers can now run North and Cohere's Command A series directly on AMD Instinct GPU-powered infrastructure —

AMD brings Cohere North into its internal enterprise AI portfolio—

Today, AMD (NASDAQ: AMD) announced it is expanding its global collaboration on multiple fronts with Cohere, the leading security-first enterprise AI company. Cohere customers will have access to AMD Instinct™ GPU-powered infrastructure for Cohere's full suite of AI offerings, including Command A, Command A Vision, Command A Translate and North. This gives enterprise and sovereign AI initiatives in Canada and around the world more choices to meet performance and TCO goals that make their AI plans real.

AMD also announced that it will integrate Cohere's North platform into its internal enterprise AI portfolio, making Cohere's technology an integral part of the AMD internal and engineering AI workloads at AMD.

"We are excited to further expand our relationship with AMD with the availability of many of our models and North on AMD Instinct GPUs. Given public and private sector customers the ability to deploy our full suite of technology across our foundational models and security-optimized enterprise AI products gives them significantly greater flexibility in how they choose to deploy Cohere's AI," said Nick Frosst, co-founder, Cohere. "AMD has a compelling TCO proposition with its AI infrastructure and is a great option for sovereign AI initiatives in Canada and globally."

"Cohere's full-stack AI solutions are now deployable on AMD Instinct infrastructure, empowering organizations and governments to scale AI with exceptional performance, efficiency, and memory capacity," said Vamsi Boppana, senior vice president, AI, AMD. "With the AMD AI computing platform, customers benefit from excellent total cost of ownership and energy efficiency – critical advantages as enterprise and governments accelerate their AI transformation."

Cohere models optimized with AMD AI Infrastructure
This announcement expands on the existing work AMD and Cohere have done to optimize Cohere's enterprise LLMs on AMD Instinct GPUs-based infrastructure.

As Cohere discussed at the AMD Advancing AI 2025 event , these models, powered by AMD, are already deployed across enterprises providing the memory bandwidth and capacity needed for long-context reasoning and complex workloads, reducing the deployment footprint and lowering total cost of ownership for customers.

With Cohere's focus on highly secure and private AI models, combined with the high-performance AMD AI infrastructure, AMD and Cohere can enable sovereign AI deployments that respect national data, security, and compliance requirements. Offering Cohere enterprise AI models on AMD AI infrastructure provides a foundation for governments and enterprises to build trusted AI systems with the flexibility to run on their own terms.

Supporting Resources

About AMD
For more than 55 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work and play. AMD employees are focused on building leadership high-performance and adaptive products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website , blog , LinkedIn , Facebook and X pages.


Aaron Grabein AMD Communications +1 737-256-9518 aaron.grabein@AMD.com Liz Stine AMD Investor Relations +1 720-652-3965 liz.stine@AMD.com

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

AMD
The Conversation (0)
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today reports financial results for its first quarter of... Keep Reading...
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. John Bathery to its Board of Directors,... Keep Reading...
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer's disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth... Keep Reading...
InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reports financial results for the second quarter of the fiscal year 2025... Keep Reading...
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a significant safety marginDose ranging studies completed InMed Pharmaceuticals Inc. (NASDAQ:... Keep Reading...
Homerun Resources Inc. Engages Minerali Industriali Engineering for Third Party Confirmation Testing and Reporting on the Santa Maria Eterna Silica Sand for the Manufacture of Antimony-Free Solar Glass as a Key Deliverable Under the Solar Plant Bankable Feasibility Study

Homerun Resources Inc. Engages Minerali Industriali Engineering for Third Party Confirmation Testing and Reporting on the Santa Maria Eterna Silica Sand for the Manufacture of Antimony-Free Solar Glass as a Key Deliverable Under the Solar Plant Bankable Feasibility Study

Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to announce that the Company has secured the services of Minerali Industriali Engineering Srl ("MIE") to perform laboratory and pilot-scale testing of high-purity, low-iron silica sand from Santa... Keep Reading...
Hands using a smartphone for stock trading with "Buy" and "Sell" buttons displayed.

Tech Weekly: Stock Valuation Fears Persist as US Government Reopens

Welcome to the Investing News Network's weekly brief on tech news and tech stocks driving the markets. We also break down next week's catalysts to watch to help you prepare for the week ahead.Don't forget to follow us @INN_Technology for real-time news updates!Securities Disclosure: I, Meagen... Keep Reading...
Homerun Resources Inc. Engages DTEC Engineering to Advance Bankable Feasibility Study for the First Antimony-Free Solar Glass Project in the Americas

Homerun Resources Inc. Engages DTEC Engineering to Advance Bankable Feasibility Study for the First Antimony-Free Solar Glass Project in the Americas

Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to announce that the Company has engaged DTEC PMP GmbH ("DTEC") to deliver a Bankable Feasibility Study (BFS) for Homerun's antimony-free solar glass manufacturing project. The study will leverage... Keep Reading...
Upcoming Meeting Dates - November 10, 2025

Upcoming Meeting Dates - November 10, 2025

The following is a list of Upcoming Meeting Dates for Reporting Issuers in Canada. The data is supplied by Issuing Companies through the service of CDS Clearing and Depository Services Inc. Company Name Record Date Meeting Date Type ATLANTIS SUBMARINES INTL HLDS November 24, 2025 December 29,... Keep Reading...
Closeup of banknote with overlaid stock market data and charts.

Tech Weekly: Tech Stocks Feel the Heat Amid Valuation Fears

Welcome to the Investing News Network's weekly brief on tech news and tech stocks driving the markets. We also break down next week's catalysts to watch to help you prepare for the week ahead.Don't forget to follow us @INN_Technology for real-time news updates!Securities Disclosure: I, Meagen... Keep Reading...
Westport Reveals CNG Solution for Natural Gas HPDI Engines and North America's Clean Transportation Future

Westport Reveals CNG Solution for Natural Gas HPDI Engines and North America's Clean Transportation Future

Westport Fuel Systems Inc. ("Westport") (TSX:WPRT Nasdaq: WPRT), a supplier of alternative fuel systems and components for the global transportation industry, today announces a breakthrough solution designed to dramatically expand the addressable market for HPDI™ while significantly improving... Keep Reading...

Latest Press Releases

Related News